Aopia Biosciences officially launches the NanoEX™ Automated Bio-nanoparticle Isolation Platform on May 12th, 2024 at the 2024 ISEV annual conference, Melbourne, Australia. The NanoEX™ is the next generation platform for isolating bio-nanoparticles, such as extracellular vesicles (EV), lipid nanoparticles (LNP), and gene therapy vectors. The system uses a patent-pending Asymmetric Nanopore Membrane (ANM) technology to […]
Aopia was selected as Top 4 companies from over 300 companies from 26 countries to compete in the 2023 MedTech BioTools Innovator Capstone event.
Aopia will be presenting the ANM technology and its applications for high efficiency EV isolation and large-scale exosome production at the International Society for Extracellular Vesicles (ISEV) EV Technology and Methods Summit in Honolulu, Hawaii from Nov 16 to Nov 18, 2022.
Aopia Biosciences secured seed round of investment to support the development and commercialization of NanoEX™, a next-generation extracellular vesicle (EV) isolation and enrichment platform. NanoEX™ is based on the patented asymmetric nanopore membrane (ANM) technology and can deliver unparalleled EV isolation efficiency and purity. This highly scalable platform not only allows fast purification of exosomes […]